Amylyx Pharmaceuticals, Inc. (AMLX) — Total Liabilities
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $27.39M | -5.1% |
| 2024 | $28.87M | -65.6% |
| 2023 | $84.02M | +65.2% |
| 2022 | $50.85M | +191.7% |
| 2021 | $17.43M | — |
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $27.39M | -5.1% |
| 2024 | $28.87M | -65.6% |
| 2023 | $84.02M | +65.2% |
| 2022 | $50.85M | +191.7% |
| 2021 | $17.43M | — |